XECHEM INTERNATIONAL INC
NT 10-K, 1997-03-27
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIOCORAL INC, SC 13D, 1997-03-27
Next: QUINTILES TRANSNATIONAL CORP, DEF 14A, 1997-03-27



                            U.S. SECURITIES AND EXCHANGE COMMISSION
                                    WASHINGTON, D.C.  20549

                                  NOTIFICATION OF LATE FILING

                                          FORM 12b-25

SEC File Number     0-23788                      Cusip Number     983895
               ------------------------------                 -----------

                                          [Check One]
      |X| Form 10-K |_| Form 20-F |_| Form 11-K |_| Form 10-Q |_| Form N-SAR

                      For the Period Ended:       December 31, 1996

                      [ ] Transition  Report on Form 10-K 
                      [ ] Transition  Report on  Form  20-F
                      [ ] Transition  Report  on  Form  11-K
                      [ ] Transition  Report on Form 10-Q 
                      [ ] Transition  Report on Form N-SAR For the Transition
                           Period Ended

                    Read Instructions [on back page] Before Preparing Form.
                                     Please Print or Type
   Nothing in this form shall be  constructed  to imply that the  Commission has
verified any information contained herein
      If                  the  notification  relates  to a portion of the filing
                          checked  above,  identify  the  Item[s]  to which  the
                          notification relates:


PART I - REGISTRANT INFORMATION
Full Name of Registrant:     XECHEM INTERNATIONAL, INC.
Former Name if Applicable:
Address of Principal Executive Office [Street and Number]:
100 JERSEY AVENUE B310
City, State and Zip Code:
NEW BRUNSWICK, NEW JERSEY 08901
PART II - RULES 12b-25[b] and [c]
If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25[b], the following should
be completed.
                                  [Check box if appropriate]

        [a] The reasons  described in reasonable detail in Part III of this form
            could not be eliminated without unreasonable effort or expenses;

[X]         [b] The subject annual report, semi-annual report, transition report
            on Form 10-K,  Form 2-F, Form 11-K, Form N-SAR, or portion thereof ,
            will be filed on or before the fifteenth  calendar day following the
            prescribed due date; or the subject  quarterly  report or transition
            report on Form 10-Q,  or portion  thereof will be filed on or before
            the fifth calendar day following the prescribed due date; and

        [c] The  accountant's  statement  or  other  exhibit  required  by  Rule
            12b-25[c] has been attached if applicable.



PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q
or N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed  time period.  [Attach Extra Sheet if Needed] The Company has not
yet received audited financial statements from its independent accountants.  The
Company  expects to receive such  financial  statements  within the next fifteen
[15] days.
PART IV - OTHER INFORMATION
     [1]  Name and telephone number of person to contact in regard to this
           notification

        Leonard A. Mudry                        908               247-3300
           [Name]                            [Area Code]         [Telephone No.]

     [2] Have all other periodic  reports  required under Section 13 or 15[d] of
         the Securities and Exchange Act of 1934 or Section 30 of the Investment
         Company Act of 1940 during the preceding 12 months [or for such shorter
         period that the  registrant  was  required to file such  reports]  been
         filed? If answer is no, identify report[s]. [X ] Yes [ ] No



     [3] Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be 
         reflected by the earnings statements to be included in the subject
          report or portion
         thereof?      [   ] Yes     [X] No

         If  so,  attach  an  explanation  of  the  anticipated   change,   both
         narratively and quantitatively,  and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

                                      XECHEM INTERNATIONAL, INC.
                           [Name of Registrant as Specified in Charter]

has caused this notification to be signed on its behalf by the undersigned
 thereunto duly authorized.

Date           March 25, 1997                           By /s/ Leonard A. Mudry
                                                            Leonard A. Mudry,
                                                   Vice President and Operations

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
[other than an executive officer], evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                             ATTENTION
                    Intentional misstatements or omissions of fact constitute
                         Federal Criminal Violation  [See 18 U.S.C. 1001]

                                       GENERAL INSTRUCTIONS

1.   This form is  required by Rule  12b-25 [17 CFR  240.12b-25]  of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed  original and four conformed  copies of this form and amendments
     thereto  must be  completed  and filed  with the  Securities  and  Exchange
     Commission,  Washington,  D.C.  20549,  in accordance  with Rule 0-3 of the
     General Rules and Regulations  under the Act. The information  contained in
     or filed  with the form will be made a matter of the  public  record in the
     Commission files.

3.   A manually  signed copy of the form and  amendments  thereto shall be filed
     with each national  securities exchange on which any class of securities of
     the registrant is registered.

4    Amendments to the notifications must also be filed on form 12b-25, but need
     not restate information that has been correctly  furnished.  The form shall
     be clearly identified as an amendment notification.

5.   Electronic Filers - This form shall not be used by electronic filers unable
     to timely  file a report  solely  due to  electronic  difficulties.  Filers
     unable  to  submit  a  report  within  the time  period  prescribed  due to
     difficulties  in  electronic  filing  should comply with either Rule 201 or
     Rule 202 of  Regulation  S-T or apply  for an  adjustment  in  filing  date
     pursuant to Rule 13(b) of Regulation S-T




<PAGE>





                                                                     EXHIBIT A

                                     MOORE STEPHENS, P.C.
                                 CERTIFIED PUBLIC ACCOUNTANTS
                                340 NORTH AVENUE EAST, SUITE 6
                                CRANFORD, NEW JERSEY 07016-2461






                                                  March 25, 1997



Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

Gentlemen:

         We are retained by Xechem International,  Inc. as independent certified
public  accountants  to report on the financial  statements at December 31, 1996
and  for the  fiscal  years  then  ended.  We have  endeavored,  with  the  full
cooperation  of the Company,  to obtain the  necessary  information  to meet the
filing  requirements  for Form 10-K, both as to form and timeliness.  Due to the
extensive  period  of time  and the  related  delay in  developing  data for the
financial statements,  we will not have sufficient time to complete our audit by
March 31,  1997  which is the  required  filing  date for the  Company's  annual
report, without unreasonable effort and expense.

                                Very truly yours,





                              MOORE STEPHENS, P.C.






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission